Hypoxia-inducible expression of tumor-associated carbonic anhydrases CC Wykoff, NJP Beasley, PH Watson, KJ Turner, J Pastorek, A Sibtain, ... Cancer research 60 (24), 7075-7083, 2000 | 1525 | 2000 |
Histone H3 and U2 snRNA DNA sequences and arthropod molecular evolution DJ Colgan, A McLauchlan, GDF Wilson, SP Livingston, GD Edgecombe, ... Australian Journal of Zoology 46 (5), 419-437, 1998 | 980 | 1998 |
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry GD Wilson, NJ McNally, S Dische, MI Saunders, C Des Rochers, ... British journal of cancer 58 (4), 423-431, 1988 | 349 | 1988 |
Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 335 | 2019 |
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 332 | 2020 |
Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation … SM Bentzen, BM Atasoy, FM Daley, S Dische, PI Richman, MI Saunders, ... J Clin Oncol 23 (24), 5560-5567, 2005 | 330 | 2005 |
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and … MI Koukourakis, SM Bentzen, A Giatromanolaki, GD Wilson, FM Daley, ... Journal of Clinical Oncology 24 (5), 727-735, 2006 | 324 | 2006 |
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. CS Potten, M Kellett, SA Roberts, DA Rew, GD Wilson Gut 33 (1), 71-78, 1992 | 288 | 1992 |
Measuring proliferation in breast cancer: practicalities and applications MJ Beresford, GD Wilson, A Makris Breast Cancer Research 8, 1-11, 2006 | 274 | 2006 |
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON PJ Hoskin, A Sibtain, FM Daley, GD Wilson British journal of cancer 89 (7), 1290-1297, 2003 | 266 | 2003 |
Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 247 | 2021 |
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry GD Wilson, NJ McNally, E Dunphy, H Kärcher, R Pfragner Cytometry: The Journal of the International Society for Analytical Cytology …, 1985 | 245 | 1985 |
Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 236 | 2020 |
The importance of CD44 as a stem cell biomarker and therapeutic target in cancer R Thapa, GD Wilson Stem cells international 2016, 2016 | 228 | 2016 |
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer RJ Burcombe, A Makris, PI Richman, FM Daley, S Noble, M Pittam, ... British journal of cancer 92 (1), 147-155, 2005 | 220 | 2005 |
Biologic basis for combining drugs with radiation GD Wilson, SM Bentzen, PM Harari Seminars in radiation oncology 16 (1), 2-9, 2006 | 215 | 2006 |
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis AC Begg, K Haustermans, AAM Hart, S Dische, M Saunders, B Zackrisson, ... Radiotherapy and Oncology 50 (1), 13-23, 1999 | 189 | 1999 |
The confluence of stereotactic ablative radiotherapy and tumor immunology SE Finkelstein, R Timmerman, WH McBride, D Schaue, SE Hoffe, ... Clinical and Developmental Immunology 2011, 2011 | 177 | 2011 |
Cell production rates in human tissues and tumours and their significance. Part II: clinical data DA Rew, GD Wilson European Journal of Surgical Oncology (EJSO) 26 (4), 405-417, 2000 | 174 | 2000 |
Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? JM Brown, G Wilson Cancer biology & therapy 2 (5), 477-490, 2003 | 156 | 2003 |